Skip to content

AARD AARD Earnings yield

Earnings yield at other companies

AbbVie logo
AbbVieABBV
0.9%-0.2pp
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
-8.1%-4.0pp
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-3.4%-0.8pp
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-13.6%-3.0pp
Viking Therapeutics logo
Viking TherapeuticsVKTX
-12.6%-31.7pp
Arvinas logo
ArvinasARVN
-32.6%-56.3pp

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

Based on trailing twelve months.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's earnings yield?
AARD (AARD) reported earnings yield of -85% in Q1 2026.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.